Inhibitor Therapeutics, Inc. Stock Issued During Period, Value, Employee Benefit Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Inhibitor Therapeutics, Inc. stock issued during period, value, employee benefit plan for the quarter ending 2026-06-30 was $33.00K, a 120.00% increase year-over-year.
- Inhibitor Therapeutics, Inc. stock issued during period, value, employee benefit plan for the quarter ending 2025-06-30 was $15.00K.
- Inhibitor Therapeutics, Inc. stock issued during period, value, employee benefit plan for the quarter ending 2024-03-31 was $21.00K.
- Inhibitor Therapeutics, Inc. stock issued during period, value, employee benefit plan for the quarter ending 2023-09-30 was $1.53K.
- Inhibitor Therapeutics, Inc. stock issued during period, value, employee benefit plan for fiscal 2025 was $15.00K, a 28.57% decline from fiscal 2024.
- Inhibitor Therapeutics, Inc. stock issued during period, value, employee benefit plan for fiscal 2024 was $21.00K, a 52.35% increase from fiscal 2023.
- Inhibitor Therapeutics, Inc. stock issued during period, value, employee benefit plan for fiscal 2023 was $13.78K.
| Period end | Stock Issued During Period, Value, Employee Benefit Plan 3 month | Stock Issued During Period, Value, Employee Benefit Plan 12 month |
|---|---|---|
| 2026-06-30 | $33.00K 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $15.00K 10-K · filed 2026-03-26 | |
| 2025-06-30 | $15.00K 10-Q · filed 2026-08-14 | |
| 2024-12-31 | $21.00K 10-K · filed 2026-03-26 | |
| 2024-03-31 | $21.00K 10-Q · filed 2025-11-13 | |
| 2023-12-31 | $13.78K 10-K · filed 2025-03-28 | |
| 2023-09-30 | $1.53K 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $12.25K 10-Q · filed 2024-11-12 |